Pfm Health Sciences, LP Alkermes Plc. Transaction History
Pfm Health Sciences, LP
- $1.71 Billion
- Q3 2024
A detailed history of Pfm Health Sciences, LP transactions in Alkermes Plc. stock. As of the latest transaction made, Pfm Health Sciences, LP holds 205,073 shares of ALKS stock, worth $6.1 Million. This represents 0.34% of its overall portfolio holdings.
Number of Shares
205,073
Previous 205,073
-0.0%
Holding current value
$6.1 Million
Previous $4.94 Million
16.13%
% of portfolio
0.34%
Previous 0.25%
Shares
4 transactions
Others Institutions Holding ALKS
# of Institutions
364Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$866 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$564 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$387 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$377 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$273 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.89B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...